HRP20110624T1 - Supstituirani piperazinilpirazini kao antagonisti receptora 5-ht7 - Google Patents
Supstituirani piperazinilpirazini kao antagonisti receptora 5-ht7 Download PDFInfo
- Publication number
- HRP20110624T1 HRP20110624T1 HR20110624T HRP20110624T HRP20110624T1 HR P20110624 T1 HRP20110624 T1 HR P20110624T1 HR 20110624 T HR20110624 T HR 20110624T HR P20110624 T HRP20110624 T HR P20110624T HR P20110624 T1 HRP20110624 T1 HR P20110624T1
- Authority
- HR
- Croatia
- Prior art keywords
- compound according
- pharmaceutically acceptable
- acceptable salt
- fluorine
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96834407P | 2007-08-28 | 2007-08-28 | |
| US4875208P | 2008-04-29 | 2008-04-29 | |
| PCT/US2008/073543 WO2009029439A1 (en) | 2007-08-28 | 2008-08-19 | Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110624T1 true HRP20110624T1 (hr) | 2011-09-30 |
Family
ID=39873874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110624T HRP20110624T1 (hr) | 2007-08-28 | 2008-08-19 | Supstituirani piperazinilpirazini kao antagonisti receptora 5-ht7 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8048884B2 (enExample) |
| EP (1) | EP2188268B1 (enExample) |
| JP (1) | JP5290293B2 (enExample) |
| KR (1) | KR101148616B1 (enExample) |
| CN (1) | CN101790522B (enExample) |
| AR (1) | AR068111A1 (enExample) |
| AT (1) | ATE520673T1 (enExample) |
| AU (1) | AU2008293715B2 (enExample) |
| BR (1) | BRPI0816468A2 (enExample) |
| CA (1) | CA2694911C (enExample) |
| CY (1) | CY1111848T1 (enExample) |
| DK (1) | DK2188268T3 (enExample) |
| EA (1) | EA017809B1 (enExample) |
| HR (1) | HRP20110624T1 (enExample) |
| MX (1) | MX2010002352A (enExample) |
| PE (1) | PE20090629A1 (enExample) |
| PL (1) | PL2188268T3 (enExample) |
| PT (1) | PT2188268E (enExample) |
| SI (1) | SI2188268T1 (enExample) |
| TW (1) | TW200914020A (enExample) |
| WO (1) | WO2009029439A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI118473B (fi) | 2006-02-17 | 2007-11-30 | Outotec Oyj | Menetelmä kuparin talteenottamiseksi kuparisulfidimalmista |
| EA016787B1 (ru) * | 2007-10-12 | 2012-07-30 | Эли Лилли Энд Компани | Антагонисты рецептора 5-нт |
| CN103119034B (zh) | 2010-04-16 | 2016-08-03 | 拜耳知识产权有限责任公司 | 作为害虫防治剂的杂环化合物 |
| CN103857670B (zh) | 2011-10-11 | 2016-03-23 | Ucb医药有限公司 | 2-氧代-哌啶基衍生物 |
| FR2995605B1 (fr) | 2012-09-18 | 2014-09-19 | Sanofi Sa | Derives de macrolides, leur preparation et leur application therapeutique. |
| MA39145B1 (fr) | 2013-12-20 | 2018-05-31 | Esteve Labor Dr | Dérivés de pipérazine ayant une activité multimode contre la douleur |
| TWI648265B (zh) | 2017-03-03 | 2019-01-21 | 國立臺灣大學 | ８－苯基異喹啉及其醫藥組合物用於治療腸躁症候群 |
| KR102014335B1 (ko) * | 2017-12-01 | 2019-08-26 | 한국과학기술연구원 | 5-ht7 수용체의 조절제로 작용하는 아릴피라졸릴피페라진 또는 아릴피라졸릴다이아제페인의 유도체 및 이를 포함하는 중추신경계 질환 치료 또는 예방용 약학 조성물 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1153013B1 (en) * | 1999-02-10 | 2007-10-31 | Eli Lilly And Company | 5-ht1f agonists |
| US20030008880A1 (en) * | 2001-05-02 | 2003-01-09 | Pfizer Inc. | 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity |
| CA2514656A1 (en) * | 2003-01-31 | 2004-08-12 | Pfizer Products Inc. | 5ht7 antagonists and inverse agonists |
| US7153858B2 (en) * | 2003-01-31 | 2006-12-26 | Epix Delaware, Inc. | Arylpiperazinyl compounds |
-
2008
- 2008-08-01 TW TW097129418A patent/TW200914020A/zh unknown
- 2008-08-19 AT AT08798144T patent/ATE520673T1/de active
- 2008-08-19 KR KR1020107004378A patent/KR101148616B1/ko not_active Expired - Fee Related
- 2008-08-19 SI SI200830392T patent/SI2188268T1/sl unknown
- 2008-08-19 HR HR20110624T patent/HRP20110624T1/hr unknown
- 2008-08-19 CN CN2008801048354A patent/CN101790522B/zh not_active Expired - Fee Related
- 2008-08-19 AU AU2008293715A patent/AU2008293715B2/en not_active Ceased
- 2008-08-19 PL PL08798144T patent/PL2188268T3/pl unknown
- 2008-08-19 CA CA2694911A patent/CA2694911C/en not_active Expired - Fee Related
- 2008-08-19 JP JP2010523034A patent/JP5290293B2/ja not_active Expired - Fee Related
- 2008-08-19 MX MX2010002352A patent/MX2010002352A/es active IP Right Grant
- 2008-08-19 EA EA201070321A patent/EA017809B1/ru not_active IP Right Cessation
- 2008-08-19 BR BRPI0816468 patent/BRPI0816468A2/pt not_active Application Discontinuation
- 2008-08-19 EP EP08798144A patent/EP2188268B1/en not_active Not-in-force
- 2008-08-19 WO PCT/US2008/073543 patent/WO2009029439A1/en not_active Ceased
- 2008-08-19 DK DK08798144.5T patent/DK2188268T3/da active
- 2008-08-19 US US12/447,546 patent/US8048884B2/en not_active Expired - Fee Related
- 2008-08-19 PT PT08798144T patent/PT2188268E/pt unknown
- 2008-08-27 PE PE2008001449A patent/PE20090629A1/es not_active Application Discontinuation
- 2008-08-27 AR ARP080103721A patent/AR068111A1/es unknown
-
2011
- 2011-09-20 CY CY20111100910T patent/CY1111848T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN101790522B (zh) | 2012-06-27 |
| AU2008293715A1 (en) | 2009-03-05 |
| US20100075976A1 (en) | 2010-03-25 |
| AR068111A1 (es) | 2009-11-04 |
| EA017809B1 (ru) | 2013-03-29 |
| BRPI0816468A2 (pt) | 2015-03-24 |
| CA2694911A1 (en) | 2009-03-05 |
| US8048884B2 (en) | 2011-11-01 |
| PL2188268T3 (pl) | 2011-12-30 |
| CA2694911C (en) | 2013-05-07 |
| EP2188268A1 (en) | 2010-05-26 |
| JP2010537994A (ja) | 2010-12-09 |
| CY1111848T1 (el) | 2015-10-07 |
| CN101790522A (zh) | 2010-07-28 |
| DK2188268T3 (da) | 2011-10-03 |
| PE20090629A1 (es) | 2009-05-16 |
| ATE520673T1 (de) | 2011-09-15 |
| PT2188268E (pt) | 2011-10-03 |
| EP2188268B1 (en) | 2011-08-17 |
| SI2188268T1 (sl) | 2011-11-30 |
| TW200914020A (en) | 2009-04-01 |
| AU2008293715B2 (en) | 2013-09-19 |
| KR20100038117A (ko) | 2010-04-12 |
| JP5290293B2 (ja) | 2013-09-18 |
| MX2010002352A (es) | 2010-08-04 |
| KR101148616B1 (ko) | 2012-05-21 |
| WO2009029439A1 (en) | 2009-03-05 |
| EA201070321A1 (ru) | 2010-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110624T1 (hr) | Supstituirani piperazinilpirazini kao antagonisti receptora 5-ht7 | |
| KR102488479B1 (ko) | 인플루엔자 바이러스 감염에 사용하기 위한 인돌 | |
| HRP20120830T1 (hr) | Imidazolkarboksamidi | |
| HRP20240157T1 (hr) | Deuterirani derivati lanifibranora | |
| EP4467549A3 (en) | Intermediates of n-(3-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)benzamide derivatives | |
| CY1108913T1 (el) | Παραγωγα 4 (φαινυλ-πιπεραζινυλ-μεθυλ) βενζαμιδιου και η χρηση τους για τη θεραπευτικη αντιμετωπιση του πονου, του αγχους ή γαστρεντερικων διαταραχων | |
| HRP20241768T1 (hr) | Heterociklički spoj | |
| ME02675B (me) | Novi derivati cikloheksilamina sa aktivnostima beta2 adrenergijskog agonista i m3 muscarinskog antagonista | |
| EA200901379A1 (ru) | Производные никотиновой кислоты как модуляторы метаботропных глутаматных рецепторов 5 подтипа | |
| ME02373B (me) | Biciklična heterociklična jedinjenja kao inhibitori protein tirozin kinaze | |
| HRP20120202T1 (hr) | AMIDOFENOKSIINDAZOLI, KORISNI KAO INHIBITORI c-MET | |
| RU2006131304A (ru) | Производные имидазо[1,2-c]пиримидинилуксусной кислоты | |
| HRP20211675T1 (hr) | Inhibitori kinaze pirazolil hinoksalina | |
| NZ724837A (en) | 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof | |
| CY1114803T1 (el) | Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης | |
| HRP20231608T1 (hr) | Derivati piridinil sulfonamida, njihovi farmaceutski pripravci i njihove uporabe | |
| SG178902A1 (en) | (thio)morpholine derivatives as s1p modulators | |
| MX383762B (es) | Derivados de glutarimida, uso de los mismos, composición farmacéutica basada en los mismos y métodos para producir derivados de glutarimida. | |
| AR114420A1 (es) | Derivados de 2,4-diaminoquinazolina y usos médicos de los mismos | |
| HRP20120257T1 (hr) | Antagonisti receptora 5-ht7 | |
| JP2010537994A5 (enExample) | ||
| AR046077A1 (es) | Derivados de n4- oxicarbonilcitimidina, procedimientos de eleaboracion y usos de los mismos | |
| TW200604198A (en) | Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists | |
| RU2017112299A (ru) | Способ получения ароматического гетероциклического соединения, применяемого в качестве селективного ингибитора киназы jak1, и применение ароматического гетероциклического соединения | |
| HRP20240697T1 (hr) | Derivati n-metil, n-(6-(metoksi)piridazin-3-il) amina kao modulatori autotaksina (atx) za liječenje upalnih bolesti dišnih puteva ili fibroznih bolesti |